More Images
Product: Artificial intelligence
Top Line: 20/20NOW
has combined artificial intelligence with fundus imaging within its ocular telehealth eye exams to enable early detection of retinal disease such as diabetic retinopathy.
The combination of AI and fundus imaging within telehealth eye exams provides both increased access to care and earlier detection of diabetic retinopathy to prevent unnecessary vision loss, the company said.
Close Up: Through the use of FDA-approved equipment and software, retinal images are enhanced using the 20/20NOW’s Eyelogic AI program, allowing optometrists to diagnose with more confidence conditions that affect the retina. With traditional testing, some retinopathy may go undetected in its early stages, the company noted. Given the widespread epidemic of diabetes, optometrists who work with 20/20NOW’s ocular telehealth system can now utilize this new technology to identify diabetic retinopathy and refer patients for treatment, which ultimately can prevent blindness and other health complications.
“While other technology advancements are being used to bypass eye care providers, 20/20NOW is working with optometrists by providing the best tools to diagnose refractive and ocular medical conditions,” said 20/20NOW’s subject matter advisor, Bryan M. Rogoff, OD, MBA, CPHM.
“By also providing optometrists with artificial intelligence to enhance retinal images, they’re able to diagnose with more confidence during a telehealth examination. This is just one example of 20/20NOW’s advancement within ocular telehealth exams. Keeping the clinical assessment and control with the optometrist is paramount for patients, providers and payers. This strategy increases the sensitivity and efficacy of the exams, which ultimately lower healthcare costs.”
Vital Stats: The accompanying photos consist of two sets of retinal images. The first set of photos represent a diagnosis of diabetic retinopathy. A conventional image is followed by an image that is enhanced with 20/20NOW’s Eyelogic AI program. The circles demonstrate areas of low, medium and high risks of dot hemorrhages and exudates.
In the second set of photos, which represents a diagnosis of dry age-related macular degeneration, a conventional image is followed by one enhanced by Eyelogic AI. It demonstrates focal areas of concern of hard exudates and drusen.
www.for2020now.com